Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.

Zhang T, Han W, Zhao K, Yang W, Lu X, Jia Y, Qin A, Qian Y.

FASEB J. 2019 Apr;33(4):5399-5410. doi: 10.1096/fj.201801797R. Epub 2019 Jan 31.

PMID:
30702934
2.

Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.

Chai L, Zhou K, Wang S, Zhang H, Fan N, Li J, Tan X, Hu L, Fan X.

Cell Physiol Biochem. 2018;48(5):2123-2133. doi: 10.1159/000492554. Epub 2018 Aug 15.

3.

Psoralen stimulates osteoblast proliferation through the activation of nuclear factor-κB-mitogen-activated protein kinase signaling.

Li F, Li Q, Huang X, Wang Y, Ge C, Qi Y, Guo W, Sun H.

Exp Ther Med. 2017 Sep;14(3):2385-2391. doi: 10.3892/etm.2017.4771. Epub 2017 Jul 11.

4.

Osteoblast-Specific Loss of IGF1R Signaling Results in Impaired Endochondral Bone Formation During Fracture Healing.

Wang T, Wang Y, Menendez A, Fong C, Babey M, Tahimic CG, Cheng Z, Li A, Chang W, Bikle DD.

J Bone Miner Res. 2015 Sep;30(9):1572-84. doi: 10.1002/jbmr.2510.

5.

WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.

Cheon YH, Kim JY, Baek JM, Ahn SJ, Jun HY, Erkhembaatar M, Kim MS, Lee MS, Oh J.

J Bone Miner Res. 2016 Feb;31(2):403-15. doi: 10.1002/jbmr.2612. Epub 2015 Aug 29.

6.

Coenzyme q10 regulates osteoclast and osteoblast differentiation.

Moon HJ, Ko WK, Jung MS, Kim JH, Lee WJ, Park KS, Heo JK, Bang JB, Kwon IK.

J Food Sci. 2013 May;78(5):H785-891. doi: 10.1111/1750-3841.12116. Epub 2013 Apr 12.

PMID:
23582186
7.

Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway.

Li L, Sapkota M, Gao M, Choi H, Soh Y.

Eur J Pharmacol. 2017 Nov 15;815:202-209. doi: 10.1016/j.ejphar.2017.09.015. Epub 2017 Sep 15.

PMID:
28919027
8.

Osteogenic activity of silymarin through enhancement of alkaline phosphatase and osteocalcin in osteoblasts and tibia-fractured mice.

Kim JL, Park SH, Jeong D, Nam JS, Kang YH.

Exp Biol Med (Maywood). 2012 Apr;237(4):417-28. doi: 10.1258/ebm.2011.011376. Epub 2012 Apr 10.

PMID:
22496431
9.

Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation.

Han SY, Lee KH, Kim YK.

Int J Mol Med. 2018 Jul;42(1):331-345. doi: 10.3892/ijmm.2018.3603. Epub 2018 Mar 30.

11.

CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.

Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS, Oh J.

Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.

PMID:
26103094
12.

TRPV1 deletion impaired fracture healing and inhibited osteoclast and osteoblast differentiation.

He LH, Liu M, He Y, Xiao E, Zhao L, Zhang T, Yang HQ, Zhang Y.

Sci Rep. 2017 Feb 22;7:42385. doi: 10.1038/srep42385.

13.

Irisin promotes proliferation but inhibits differentiation in osteoclast precursor cells.

Ma Y, Qiao X, Zeng R, Cheng R, Zhang J, Luo Y, Nie Y, Hu Y, Yang Z, Zhang J, Liu L, Xu W, Xu CC, Xu L.

FASEB J. 2018 May 17:fj201700983RR. doi: 10.1096/fj.201700983RR. [Epub ahead of print]

PMID:
29771602
14.

Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.

Kim JY, Cheon YH, Kwak SC, Baek JM, Yoon KH, Lee MS, Oh J.

J Bone Miner Res. 2014 Jul;29(7):1541-53. doi: 10.1002/jbmr.2183.

15.

EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.

Zhang M, Ho HC, Sheu TJ, Breyer MD, Flick LM, Jonason JH, Awad HA, Schwarz EM, O'Keefe RJ.

J Bone Miner Res. 2011 Apr;26(4):792-802. doi: 10.1002/jbmr.272.

16.

DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.

Cai X, Xing J, Long CL, Peng Q, Humphrey MB.

J Bone Miner Res. 2017 Nov;32(11):2207-2218. doi: 10.1002/jbmr.3205. Epub 2017 Aug 2.

17.

Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.

Bergdolt S, Kovtun A, Hägele Y, Liedert A, Schinke T, Amling M, Huber-Lang M, Ignatius A.

PLoS One. 2017 Jun 14;12(6):e0179512. doi: 10.1371/journal.pone.0179512. eCollection 2017.

18.

Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.

Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N.

Comp Biochem Physiol A Mol Integr Physiol. 2013 Sep;166(1):74-80. doi: 10.1016/j.cbpa.2013.04.023. Epub 2013 Apr 28.

PMID:
23632157
19.

Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.

Khedgikar V, Kushwaha P, Gautam J, Verma A, Changkija B, Kumar A, Sharma S, Nagar GK, Singh D, Trivedi PK, Sangwan NS, Mishra PR, Trivedi R.

Cell Death Dis. 2013 Aug 22;4:e778. doi: 10.1038/cddis.2013.294.

20.

Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.

Yamaguchi M, Weitzmann MN, Murata T.

Mol Cell Biochem. 2012 Jan;359(1-2):193-203. doi: 10.1007/s11010-011-1014-z. Epub 2011 Aug 14.

PMID:
21842421

Supplemental Content

Support Center